- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on PDD in India
Total 9 results
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedSingle Dose Oral Bioequivalence Study of Vortioxetine Hemihydrobromide Orally Disintegrating TabletsMajor Depressive Disorder (MDD)India
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDD)India
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDDIndia
-
BayerActive, not recruitingCoronary Artery Disease (CAD) | Prevention of Atherothrombotic Events | Symptomatic Peripheral Artery Disease (Symptomatic PAD)India
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedMajor Depressive Disorder (MDD)United States, Australia, Bulgaria, Romania, India, Slovakia, Philippines
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedMajor Depressive Disorder (MDD)United States, Spain, Hungary, South Africa, Croatia, France, Poland, India, Canada, Sweden, Malaysia
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedMajor Depressive Disorder (MDD)Finland, Germany, Korea, Republic of, United States, Taiwan, Estonia, India, Italy, Mexico
-
Novartis PharmaceuticalsRecruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationItaly, Spain, United States, France, Thailand, Malaysia, China, Germany, India, Turkey, Belgium, Argentina, Bulgaria, Netherlands, Hungary, Greece, Portugal, Austria, Singapore, Brazil, United Kingdom
-
Boehringer IngelheimCompletedEarly Parkinson Disease (Early PD)United States, Argentina, Austria, Czech Republic, Finland, Germany, Hungary, India, Japan, Malaysia, Russian Federation, Slovakia, Taiwan, Ukraine